 | Pfizer asks FDA to greenlight COVID-19 booster shots for all adultsThe current rules: People who initially received Pfizer or Moderna vaccinations are eligible for a booster six months later if they’re 65 or older, or are at high risk of COVID-19. |
 | Taiwan gets first Pfizer-BioNTech vaccines against Covid after long delayTaiwan had been unable to buy the vaccine itself directly from BioNTech, the German company that had partnered with U.S.-based Pfizer to develop the mRNA vaccine. |
 | Blood clot risk from COVID-19 infection much higher than that after vaccination: StudySome of these events have led to restricted use of the Oxford-AstraZeneca vaccine, known as Covishield in India, in a number of countries. |
 | Pfizer-BioNtech vaccine set to be first fully approved coronavirus jabIt has submitted more data to US drug regulator from the late-stage clinical trials and ongoing vaccinations |
 | Vaccine-maker BioNTech sees profits soar in Q2The company has said the windfall from its mRNA-based coronavirus vaccine will help it to develop drugs against cancer and other diseases. |
 | Vaccine maker BioNTech to use mRNA tech to target malariaThe Germany-based company aims to begin clinical trials for a 'safe and highly effective malaria vaccine' by the end of next year. |
 | Pfizer/BioNTech to produce Covid-19 vaccine in South AfricaThe project will take time to get off the ground however, with the first African-finished vaccines not expected before 2022. |
 | COVID-19 vaccine: Pfizer jabs not the best for Delta variant, says Lancet studyPeople are less likely to develop antibody levels against the B.1.617.2 variant as high as those seen against the previously dominant B.1.1.7 variant. |
 | Bahrain offers Pfizer booster for some who got Chinese shotsThe mixing of vaccines comes as the Mideast island nation struggles through its worst wave of the virus despite being one of the top countries in the world in per-capita inoculations. |
 | Challenging Covid, India styleThe other day, I was chatting with a friend who lives in the US. She was crowing about having gone for her Covid vaccination. Pfizer, she informed me. |
 | COVID-19: Vaccine maker BioNTech says no need to waive patentsUgur Sahin, the chief executive of BioNTech, rejected the US-backed proposal to temporarily lift some intellectual property rights for vaccines in order to boost global supply during the pandemic. |
 | Joint venture by Chinese pharmaceutical company and BioNTech SE aims to make 1 billion dosesShanghai Fosun Pharmaceutical Group Co. said in a stock filing on Sunday night that the companies will invest up to $100 million each to set up the venture. |
 | Pfzier and BioNTech to donate COVID-19 vaccines for Olympic athletesDelivery of doses is set to begin this month to give Olympic delegations time to be fully vaccinated with a second shot before arriving in Tokyo for the games, which open on July 23. |
| Pfizer-BioTech seek vaccine approval for childrenThe two companies said their submission to the European Medicines Agency was based on an advanced study in more than 2,000 adolescents that showed the vaccine to be safe and effective. |
 | The Pfizer/BioNTech Covid vaccine bet that paid offThe downside is that the doses must be kept at ultralow temperatures, though Pfizer has managed to demonstrate that its vaccine can be kept up to two weeks at less intense cold. |
